Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Treatment effect on brain atrophy correlates with treatment effect on disability in multiple sclerosis.
PET imaging of demyelination and remyelination in the cuprizone mouse model for multiple sclerosis: A comparison between [(11)C]CIC and [(11)C]MeDAS.
Acute Disseminated Encephalomyelitis Presenting with Hypertensive Emergency.
The challenges of measuring disability accumulation in relapsing-remitting multiple sclerosis: evidence from interferon beta treatments.
A novel activity for fungal nitronate monooxygenase: Detoxification of the metabolic inhibitor propionate-3-nitronate.
Protective effects of 27- and 24-hydroxycholesterol against staurosporine-induced cell death in undifferentiated neuroblastoma SH-SY5Y cells.
Functional impairments in white matter syndrome of neuropsychiatric systemic lupus erythematosus are similar to those observed in patients with multiple sclerosis.
Multiple sclerosis.
Multiple sclerosis: Severity of cognitive deficits in MS linked to disease course.
Layered genetic control of DNA methylation and gene expression: a locus of multiple sclerosis in healthy individuals.
Abstracts.
The effect of triiodothyronine on maturation and differentiation of oligodendrocyte progenitor cells during remyelination following induced demyelination in male albino rat.
Modifiable environmental factors in multiple sclerosis.
Cerebrospinal fluid proteomics in multiple sclerosis.
'You are just left to get on with it': qualitative study of patient and carer experiences of the transition to secondary progressive multiple sclerosis.
Association between smoking and cognitive impairment in multiple sclerosis.
The antibody genetics of multiple sclerosis: comparing next-generation sequencing to sanger sequencing.
A Reversible and Selective Inhibitor of Monoacylglycerol Lipase Ameliorates Multiple Sclerosis.
A multicomponent T2 relaxometry algorithm for myelin water imaging of the brain.
Traumatic fatal cerebral hemorrhage in an old patient with a history of multiple sclerosis under dabigatran: a case report and review of the literature.
The Anti-Aging Protein Klotho Enhances Remyelination Following Cuprizone-Induced Demyelination.
[Neuropathology of Natalizumab-Associated Progressive Multifocal Leukoencephalopathy].
Axonal loss of retinal neurons in multiple sclerosis associated with optic radiation lesions.
Analysis of macular OCT images using deformable registration.
Treatment of neuromyelitis optica: state-of-the-art and emerging therapies.
Pages
« first
‹ previous
…
518
519
520
521
522
523
524
525
526
…
next ›
last »